Director Lawrence Gozlan Acquires 1 Million Options in Alterity Therapeutics

Lawrence Bernard Gozlan, a director of Alterity Therapeutics Ltd (ATHE), filed a Form 4 disclosing the acquisition of 1 million listed options on June 15, 2026. The options have an expiration date of June 15, 2031, and an exercise price of $1.00 per share. The transaction was acquired at $0.00 per share, indicating these were likely granted as part of director compensation. Following this transaction, Gozlan holds 1 million options. The options are held indirectly through Montoya Pty Ltd (Buttercup A/C). This filing represents standard director equity compensation disclosure and shows continued alignment of director interests with shareholders through equity-based incentives.